Search

Your search keyword '"Nester, Carla"' showing total 504 results

Search Constraints

Start Over You searched for: Author "Nester, Carla" Remove constraint Author: "Nester, Carla"
504 results on '"Nester, Carla"'

Search Results

1. DEVELOPING THERAPIES FOR C3G: REPORT OF THE KIDNEY HEALTH INITIATIVE C3G TRIAL ENDPOINTS WORK GROUP

2. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

6. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

7. Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes-a Pediatric Nephrology Research Consortium study.

8. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

9. The Significance of Hematuria in Podocytopathies

10. Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy

11. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease

12. The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

13. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

14. Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes

15. #277 Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a phase 2 study

16. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

17. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

18. An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group

19. C3 Glomerulopathy

21. Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study

23. Renin and renin blockade have no role in complement activity

29. C3 glomerulopathy — understanding a rare complement-driven renal disease

30. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

31. Renal Involvement in Children with HUS

32. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease

35. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulopathy Network

41. An international consensus approach to the management of atypical hemolytic uremic syndrome in children

44. Complement Factor I Variants in Complement-Mediated Renal Diseases

46. Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

47. Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies

49. Atypical aHUS: State of the art

Catalog

Books, media, physical & digital resources